← Open Payments lookup

ALAN EPSTEIN: Open Payments

NPI 1346211844 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$48,294 in 68 payments from 10 companies in 2025. Trend: 2023 $155,744 · 2024 $150,799 · 2025 $48,294

Speaker / faculty: $32,493Consulting: $11,952Travel & lodging: $2,216Food & beverage: $1,578Education: $55
CompanyPaymentsAmount
Janssen Biotech, Inc.14$16,096
GlaxoSmithKline, LLC.3$11,050
ABBVIE INC.16$7,478
AstraZeneca Pharmaceuticals LP12$3,813
SOBI, INC4$2,810
Janssen Scientific Affairs, LLC1$2,565
Boehringer Ingelheim Pharmaceuticals, Inc.2$2,073
Invivyd Inc1$2,013
Amgen Inc.14$379
PFIZER INC.1$18

Products named: TREMFYA, BENLYSTA, SKYRIZI, SAPHNELO, PEMGARDA, RINVOQ, OTEZLA, UPLIZNA.

Industry payments across PA — which companies pay providers there.